Patents by Inventor Varghese Palathumpat

Varghese Palathumpat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD45RB antibodies
    Patent number: 7265212
    Abstract: Antibodies which specifically recognize the human CD45 isoform RB are presented. These antibodies may be used to block undesirable immune reactions in patients with transplant rejection and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and autoimmune diabetes. Preferred antibodies are fully human, monoclonal antibodies.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: September 4, 2007
    Assignee: Amgen Fremont Inc.
    Inventors: John S. Babcook, Ian Foltz, Chadwick T. King, Varghese Palathumpat, Xiao-Dong Yang
  • Anti-CD45RB antibodies for use in treating autoimmune disease and transplant rejection
    Publication number: 20030232009
    Abstract: Antibodies which specifically recognize the human CD45 isoform RB are presented. These antibodies may be used to block undesirable immune reactions in patients with transplant rejection and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and autoimmune diabetes.
    Type: Application
    Filed: December 2, 2002
    Publication date: December 18, 2003
    Inventors: John S. Babcook, Ian Foltz, Chadwick T. King, Varghese Palathumpat, Xiao-Dong Yang
  • Cell separation composition
    Patent number: 5789148
    Abstract: Disclosed are a kit, composition and method for cell separation. The kit includes a centrifugable container and an organosilanized silica particle-based cell separation suspension suitable for density gradient separation, containing a polylactam and sterilized by treatment with ionizing radiation. The composition includes a silanized silica particle-based suspension for cell separation which contains at least 0.05% of a polylactam, and preferably treated by ionizing radiation. Also disclosed is a method of isolating rare blood cells from a blood cell mixture.
    Type: Grant
    Filed: December 11, 1995
    Date of Patent: August 4, 1998
    Assignee: Dendreon Corporation
    Inventors: Peter Van Vlasselaer, Varghese Palathumpat